Glanbia plc is a packaged foods business based in the UK. Glanbia shares (GLB.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in Euros. Glanbia employs 7,385 staff and has a trailing 12-month revenue of around €4 billion.
|Latest market close||€N/A|
|52-week range||€7.364 - €11.4266|
|50-day moving average||€10.3361|
|200-day moving average||€9.5929|
|Wall St. target price||€19|
|Dividend yield||€0.27 (2.59%)|
|Earnings per share (TTM)||€0.514|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Glanbia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Glanbia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Glanbia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Glanbia shares trade at around 20x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71).
Glanbia's EBITDA (earnings before interest, taxes, depreciation and amortisation) is €278.1 million.
The EBITDA is a measure of a Glanbia's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||€4 billion|
|Operating margin TTM||4.75%|
|Gross profit TTM||€779.9 million|
|Return on assets TTM||3.53%|
|Return on equity TTM||9.22%|
|Market capitalisation||€3 billion|
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Glanbia.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 32.69
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Glanbia's overall score of 32.69 (as at 01/01/2019) is pretty weak – landing it in it in the 78th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Glanbia is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 12.45/100
Social score: 13.07/100
Governance score: 2.17/100
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Glanbia scored a 1 out of 5 for controversy – the highest score possible, reflecting that Glanbia has managed to keep its nose clean.
|Total ESG score||32.69|
|Total ESG percentile||77.74|
|Level of controversy||1|
Dividend payout ratio: 51.75% of net profits
Recently Glanbia has paid out, on average, around 51.75% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.59% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Glanbia shareholders could enjoy a 2.59% return on their shares, in the form of dividend payments. In Glanbia's case, that would currently equate to about €0.27 per share.
Glanbia's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 20 August 2020 (the "ex-dividend date").
Over the last 12 months, Glanbia's shares have ranged in value from as little as €7.364 up to €11.4266. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Glanbia's is 0.3463. This would suggest that Glanbia's shares are less volatile than average (for this exchange).
Glanbia plc operates as a nutrition company. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, e-Commerce, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment engages in the manufacture and sale of cheese, dairy and non-dairy nutritional and functional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment produces and sells a range of value added dairy ingredients and consumer products. This segment also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, SlimFast, BSN, Isopure, Nutramino, ABB, think!, Amazing Grass, and Body & Fit brands. The company has operations in North America, Europe, and internationally. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.